GlassScriptPhysician profile
John C Simmons
NPI 1104832724
$1,107.05
in general payments reported to CMS, 2019-2025
14 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $292 · 2021: $81.87 · 2022: $141 · 2023: $98.46 · 2024: $110 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $397.50 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $302.14 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $84.02 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $60.98 | 2019-2022 | |
| Pfizer INC. | $51.98 | 2020-2021 | |
| Abbvie INC. | $38.12 | 2023-2025 | Vraylar |
| Janssen Pharmaceuticals, INC | $35.25 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $25.81 | 2023 | Gemtesa |
| Otsuka America Pharmaceutical, INC. | $24.38 | 2022 | |
| Alnylam Pharmaceuticals INC. | $22.74 | 2023 | Givlaari |
| Indivior INC. | $18.88 | 2019 | |
| Medline Industries LP | $16.48 | 2024 | Medline Industries, INC. |
| Exact Sciences Corporation | $15.96 | 2024 | Cologuard Collection Kit |
| Allergan, INC. | $12.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.